Influence of dietary vitamin K intake on subtherapeutic oral anticoagulant therapy

34Citations
Citations of this article
49Readers
Mendeley users who have this article in their library.

Abstract

It is unclear what advice should be given to patients using vitamin K antagonists with respect to dietary vitamin K intake. We performed a nested case-control study in patients attending a Dutch anticoagulation clinic, to determine the association between vitamin K intake and subtherapeutic International Normalized Ratio (INR) values and the interaction between usual and recent vitamin K intake. Compared to patients with a normal usual vitamin K intake, those with a high vitamin K intake had a decreased risk of a subtherapeutic INR [Hazard Ratio (HR) 0·80, 95% confidence interval (CI): 0·56-1·16] and patients with a low vitamin K intake an increased risk (HR 1·33, 95% CI: 0·79-2·25). In patients with a low usual vitamin K intake, recent vitamin K intake was twice as high in cases as in controls (164 vs. 85 μg/d). Such a difference was not observed in patients with a normal or high usual vitamin K intake. Our results suggest that a high vitamin K intake reduces the risk of a low INR by lessening the influence of incidental consumption of vitamin K rich food on the INR. These findings support the recommendation for patients on vitamin K antagonists to eat a sufficient amount of vitamin-K containing foods. © 2010 Blackwell Publishing Ltd.

Cite

CITATION STYLE

APA

Rombouts, E. K., Rosendaal, F. R., & Van Der Meer, F. J. M. (2010). Influence of dietary vitamin K intake on subtherapeutic oral anticoagulant therapy. British Journal of Haematology, 149(4), 598–605. https://doi.org/10.1111/j.1365-2141.2010.08108.x

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free